139 related articles for article (PubMed ID: 17002556)
1. Transmigration: a new property of mature multinucleated osteoclasts.
Saltel F; Chabadel A; Zhao Y; Lafage-Proust MH; Clézardin P; Jurdic P; Bonnelye E
J Bone Miner Res; 2006 Dec; 21(12):1913-23. PubMed ID: 17002556
[TBL] [Abstract][Full Text] [Related]
2. The Src inhibitor AZD0530 reversibly inhibits the formation and activity of human osteoclasts.
de Vries TJ; Mullender MG; van Duin MA; Semeins CM; James N; Green TP; Everts V; Klein-Nulend J
Mol Cancer Res; 2009 Apr; 7(4):476-88. PubMed ID: 19372577
[TBL] [Abstract][Full Text] [Related]
3. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
Kupisiewicz K
Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
[TBL] [Abstract][Full Text] [Related]
4. Actin polymerization modulates CD44 surface expression, MMP-9 activation, and osteoclast function.
Samanna V; Ma T; Mak TW; Rogers M; Chellaiah MA
J Cell Physiol; 2007 Dec; 213(3):710-20. PubMed ID: 17508356
[TBL] [Abstract][Full Text] [Related]
5. Role of c-Src in cellular events associated with colony-stimulating factor-1-induced spreading in osteoclasts.
Insogna K; Tanaka S; Neff L; Horne W; Levy J; Baron R
Mol Reprod Dev; 1997 Jan; 46(1):104-8. PubMed ID: 8981371
[TBL] [Abstract][Full Text] [Related]
6. (Pre-)osteoclasts induce retraction of osteoblasts before their fusion to osteoclasts.
Perez-Amodio S; Beertsen W; Everts V
J Bone Miner Res; 2004 Oct; 19(10):1722-31. PubMed ID: 15355568
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase.
Kaji H; Sugimoto T; Kanatani M; Fukase M; Kumegawa M; Chihara K
J Bone Miner Res; 1996 Jan; 11(1):62-71. PubMed ID: 8770698
[TBL] [Abstract][Full Text] [Related]
8. Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells.
Coxon FP; Thompson K; Roelofs AJ; Ebetino FH; Rogers MJ
Bone; 2008 May; 42(5):848-60. PubMed ID: 18325866
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of green tea polyphenol (-)-epigallocatechin gallate on the expression of matrix metalloproteinase-9 and on the formation of osteoclasts.
Yun JH; Pang EK; Kim CS; Yoo YJ; Cho KS; Chai JK; Kim CK; Choi SH
J Periodontal Res; 2004 Oct; 39(5):300-7. PubMed ID: 15324350
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities.
Delaissé JM; Andersen TL; Engsig MT; Henriksen K; Troen T; Blavier L
Microsc Res Tech; 2003 Aug; 61(6):504-13. PubMed ID: 12879418
[TBL] [Abstract][Full Text] [Related]
11. A selective inhibitor of matrix metalloproteinases inhibits the migration of isolated osteoclasts by increasing the life span of podosomes.
Goto T; Maeda H; Tanaka T
J Bone Miner Metab; 2002; 20(2):98-105. PubMed ID: 11862531
[TBL] [Abstract][Full Text] [Related]
12. Osteoclast culture and resorption assays.
Bradley EW; Oursler MJ
Methods Mol Biol; 2008; 455():19-35. PubMed ID: 18463808
[TBL] [Abstract][Full Text] [Related]
13. Imatinib mesylate (Gleevec) enhances mature osteoclast apoptosis and suppresses osteoclast bone resorbing activity.
El Hajj Dib I; Gallet M; Mentaverri R; Sévenet N; Brazier M; Kamel S
Eur J Pharmacol; 2006 Dec; 551(1-3):27-33. PubMed ID: 17049513
[TBL] [Abstract][Full Text] [Related]
14. Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2003 Aug; 18(8):1404-18. PubMed ID: 12929930
[TBL] [Abstract][Full Text] [Related]
15. The relative contribution of cysteine proteinases and matrix metalloproteinases to the resorption process in osteoclasts derived from long bone and scapula.
Shorey S; Heersche JN; Manolson MF
Bone; 2004 Oct; 35(4):909-17. PubMed ID: 15454098
[TBL] [Abstract][Full Text] [Related]
16. High extracellular calcium stimulates osteoclast-like cell formation and bone-resorbing activity in the presence of osteoblastic cells.
Kaji H; Sugimoto T; Kanatani M; Chihara K
J Bone Miner Res; 1996 Jul; 11(7):912-20. PubMed ID: 8797111
[TBL] [Abstract][Full Text] [Related]
17. Actin cytoskeletal organisation in osteoclasts: a model to decipher transmigration and matrix degradation.
Saltel F; Chabadel A; Bonnelye E; Jurdic P
Eur J Cell Biol; 2008 Sep; 87(8-9):459-68. PubMed ID: 18294724
[TBL] [Abstract][Full Text] [Related]
18. A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells.
Andersen TL; del Carmen Ovejero M; Kirkegaard T; Lenhard T; Foged NT; Delaissé JM
Bone; 2004 Nov; 35(5):1107-19. PubMed ID: 15542036
[TBL] [Abstract][Full Text] [Related]
19. The migration of purified osteoclasts through collagen is inhibited by matrix metalloproteinase inhibitors.
Sato T; Foged NT; Delaissé JM
J Bone Miner Res; 1998 Jan; 13(1):59-66. PubMed ID: 9443791
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer cells inhibit spontaneous and bisphosphonate-induced osteoclast apoptosis.
Hussein O; Tiedemann K; Komarova SV
Bone; 2011 Feb; 48(2):202-11. PubMed ID: 20849994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
